JPMorgan Chase & Co. Reaffirms “Underweight” Rating for GSK (LON:GSK)
GSK (LON:GSK – Get Free Report)‘s stock had its “underweight” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a report issued on Friday, Marketbeat Ratings reports. Separately, Berenberg Bank decreased their target price on shares of GSK from GBX 1,820 ($23.56) to GBX 1,600 ($20.71) and set a “buy” rating for […]
GSK (LON:GSK – Get Free Report)‘s stock had its “underweight” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a report issued on Friday, Marketbeat Ratings reports. Separately, Berenberg Bank decreased their target price on shares of GSK from GBX 1,820 ($23.56) to GBX 1,600 ($20.71) and set a “buy” rating for […]
